Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119282 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anastasiya A Kobelyatskaya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Molecular heterogeneity in prostate cancer (PCa) is one of the key reasons underlying the differing likelihoods of recurrence after surgical treatment in individual patients of the same clinical category. In this study, we performed RNA-Seq profiling of 58 localized PCa and 43 locally advanced PCa tissue samples obtained as a result of radical prostatectomy on a cohort of Russian patients. Based on bioinformatics analysis, we examined features of the transcriptome profiles within the high-risk group, including within the most commonly represented molecular subtype, TMPRSS2-ERG. The most significantly affected biological processes in the samples were also identified, so that they may be further studied in the search for new potential therapeutic targets for the categories of PCa under consideration. The highest predictive potential was found with the EEF1A1P5, RPLP0P6, ZNF483, CIBAR1, HECTD2, OGN, and CLIC4 genes. We also reviewed the main transcriptome changes in the groups at intermediate risk of PCa—Gleason Score 7 (groups 2 and 3 according to the ISUP classification)—on the basis of which the LPL, MYC, and TWIST1 genes were identified as promising additional prognostic markers, the statistical significance of which was confirmed using qPCR validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
- National Medical Research Radiological Center, Ministry of Health of the Russian Federation, 125284 Moscow, Russia.
ORCID-Profile: Anastasiya A Kobelyatskaya, Elena A Pudova, Anastasiya V Snezhkina, Maria S Fedorova, Vladislav S Pavlov, Anastasiya O Kotelnikova, Kirill M Nyushko, George S Krasnov, Anna V Kudryavtseva
Förderung
- Russian Science Foundation
Zitieren
APA
Kobelyatskaya, A. A., Pudova, E. A., Katunina, I. V., Snezhkina, A. V., Fedorova, M. S., Pavlov, V. S., Kotelnikova, A. O., Nyushko, K. M., Alekseev, B. Y., Krasnov, G. S., & Kudryavtseva, A. V. (2023). Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119282
Vancouver
Kobelyatskaya AA, Pudova EA, Katunina IV, Snezhkina AV, Fedorova MS, Pavlov VS, et al. Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119282
BibTeX
@article{Kobelyatskaya2023,
author = {Kobelyatskaya, Anastasiya A and Pudova, Elena A and Katunina, Irina V and Snezhkina, Anastasiya V and Fedorova, Maria S and Pavlov, Vladislav S and Kotelnikova, Anastasiya O and Nyushko, Kirill M and Alekseev, Boris Y and Krasnov, George S and Kudryavtseva, Anna V},
title = {Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119282}
}
EUVIMED